Skip to content

   Pharma Publications

Neuropsychopharmacology
  • LPA1 receptors in the lateral habenula regulate negative affective states associated with alcohol withdrawal
    Published on 2023-04-14
    3 years ago
  • Robust aversive effects of trace amine-associated receptor 1 activation in mice
    Published on 2023-04-13
    3 years ago
  • Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorder
    Published on 2023-04-12
    3 years ago
  • The effects of D-Cycloserine on corticospinal excitability after repeated spaced intermittent theta-burst transcranial magnetic stimulation: A randomized controlled trial in healthy individuals
    Published on 2023-04-11
    3 years ago
  • Pharmacogenetic activation of parvalbumin interneurons in the prefrontal cortex rescues cognitive deficits induced by adolescent MK801 administration
    Published on 2023-04-11
    3 years ago
  • Membrane excitability of nucleus accumbens neurons gates the incubation of cocaine craving
    Published on 2023-04-11
    3 years ago
  • 5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice
    Published on 2023-04-04
    3 years ago
« Previous 1 … 123 124 125 126 127 … 143 Next »
Journal of Psychopharmacology
  • The mGluR2/3 agonist LY379268 reverses NMDA receptor antagonist effects on cortical gamma oscillations and phase coherence, but not working memory impairments, in mice
    Published on 2019-10-03
    7 years ago
  • Caffeine improves text reading and global perception
    Published on 2019-10-03
    7 years ago
  • Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial
    Published on 2019-10-02
    7 years ago
  • Corrigendum to The Australian Drug Harms Ranking Study
    Published on 2019-10-02
    7 years ago
  • Benzodiazepines, antidepressants and addiction: A plea for conceptual rigor and consistency
    Published on 2019-09-26
    7 years ago
  • Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression
    Published on 2019-09-26
    7 years ago
  • Social cognition impairments in long-term opiate users in treatment
    Published on 2019-09-26
    7 years ago
« Previous 1 … 123 124 125 126 127 … 145 Next »
European Neuropsychopharmacology
  • Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis
    Published on 2021-01-20
    5 years ago
  • Maternal ADHD medication use during pregnancy and the risk of ADHD in children: Importance of genetic predispositions and impact of using a sibling analysis
    Published on 2021-01-16
    5 years ago
  • Reward processing in major depressive disorder and prediction of treatment response – Neuropharm study
    Published on 2021-01-15
    5 years ago
  • Maternal crack cocaine use in rats leads to depressive- and anxiety-like behavior, memory impairment, and increased seizure susceptibility in the offspring
    Published on 2021-01-14
    5 years ago
  • Primary role for melatonin MT2 receptors in the regulation of anhedonia and circadian temperature rhythm
    Published on 2021-01-13
    5 years ago
  • A case-control study of the locus coeruleus degeneration in Alzheimer’s disease
    Published on 2021-01-09
    5 years ago
  • κ-Opioid receptors in the medial amygdaloid nucleus modulate autonomic and neuroendocrine responses to acute stress
    Published on 2021-01-07
    5 years ago
« Previous 1 … 123 124 125 126 127 … 166 Next »

   Pharma Pub